Shanghai pearl biotech co., LTD., was founded in 2010, based on the development needs of the company, will now the HM series heavy metal analyzer in China general agent sales, technical training services, instrument maintenance, reagent consumables and other technical support to Shanghai tai selected industrial co., LTD., Hunan pearl you Internet of things technology co., LTD. Is also responsible for multiple regional sales and services.
The company is headquartered in Shanghai, with branches in all major cities in the country, and the service network is throughout the country. The company implements the network management internally, relying on the advanced computer-aided design system and the computer management system, to achieve the standardized operation, in the shortest possible time to provide users with high-quality products.
The company has a complete research and development team, and in recent years, the company has made great progress in the nanomaterials modified electrochemical biosensors in detecting viruses and tumor markers, preparing new trace detectors for specific viruses or tumor markers. Electrochemical biosensors modified by nanomaterials will become an effective means for the trace detection of viruses and tumor markers, and will play a great role in promoting the early clinical diagnostic application of viruses or tumors.
A trace detector based on nanobiosensor technology will detect the following 14 tumor markers:
|
|
surveillance project |
significance of the project |
|
1 |
AFP |
cancer of the liver. Liver metastasis of digestive tract tumors |
|
2 |
CEA |
A variety of cancers |
|
3 |
CA125 |
A variety of gynecological cancers and digestive tract diseases ovarian cancer, endometrial cancer, breast cancer, gastrointestinal benign diseases |
|
4 |
CA19-9 |
A variety of digestive tract and gynecological cancers include pancreatic cancer, cholangiocarcinoma, colon cancer, gastric cancer, liver cancer, and mucinous gynecological tumors |
|
5 |
CA72-4 |
Gastric cancer, ovarian cancer, and colorectal cancer |
|
6 |
CA153 |
Breast cancer, lung cancer, and a variety of gynecological cancers |
|
7 |
HE4 |
Ovarian cancer, endometrial cancer, lung cancer; the best ovarian cancer markers |
|
8 |
ProGRP |
Small cell lung cancer; medullary thyroid carcinoma; undifferentiated large cell lung carcinoma with neuroendocrine function |
|
9 |
NSE |
Small cell lung cancer, especially small cell bronchial cancer, neuroblastoma, seminoma |
|
10 |
CYFRA21-1 |
Serum non-small-cell lung cancer (NSCLC) markers. A variety of squamous cell carcinoma, including esophageal cancer, cervical cancer, etc |
|
11 |
PSA |
prostatic carcinoma |
|
12 |
FPSA |
prostatic carcinoma |
|
13 |
TG |
Differentiating thyroid cancer |
|
14 |
Calcitonin |
medullary carcinoma of thyroid gland |